Apex Pharma has received the good manufacturing practices certificate from Congo, a development that will open the door for the local medicine-maker to export pharmaceutical products to 11 central African countries.
The certificate came from the Directorate of Pharmacy & Medicine under the public health ministry of Congo.
Sayed Hossen, head of marketing of Apex Pharma, received the certificate from Ziauddin Adil and Nazir Alam, honorary consuls of Bangladesh consulate of the Republic of Congo, recently in Dhaka, according to a press release.
Bangladesh has been exporting medicines to many countries for a long time, but the volume is relatively less in 11 central African countries, said Alam, designated honorary consul of the consulate. "This achievement has opened a new opportunity for the locally manufactured world-class medicines. This is a big milestone for the medicine industry as well as for the country as it will directly contribute to the overall economy," he said.
Apex Pharma will now move to have its six products registered for exports to Congo as well other central African countries, Hossen said.
The company is also in the process of registering its products for exports to Afghanistan, Guinea, Mali and Yemen, he said, adding that the company currently sells 135 products in the domestic market.
Dilip Kajuri, a director of Apex Pharma, was present at the event.